Mayo Clinic Center for Tuberculosis launches new TB journal

March 24, 2015

The Mayo Clinic Center for Tuberculosis, a regional training and consultation center at Mayo Clinic's campus in Rochester, Minn, is today launching a new medical journal, the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. The online journal is published by Elsevier.

"We believe that the Journal of Clinical Tuberculosis and Other Mycobacterial Diseases fills an unmet need by providing a platform for the dissemination of the results of clinically relevant research," say the editors in their inaugural editorial for the publication. They also cite the continue spread of tuberculosis as a global health problem, making it the second greatest cause of death from infectious diseases after HIV.

"We are very excited that we are launching this journal on World TB Day and hope that it will effectively advance new knowledge that will ultimately help end this terrible disease," says Editor-in-Chief Zelalem Temesgen, M.D [Za-La-Lum Tah-mezg-in]. Two other Mayo Clinic physician-researchers, Stacey Rizza, M.D. and John Wilson, M.D., will serve as associate editors. All three are members of the Division of Infectious Diseases at Mayo Clinic and members of the tuberculosis center. An editorial board composed of leading experts in the field from around the globe has already been established to help advance the journal's mission.

The international journal will publish research on all aspects of tuberculosis, including epidemiology, clinical investigation, transmission, diagnosis, treatment, drug-resistance, and public policy. It will also publish articles related to non-tuberculous mycobacteria, including epidemiology, microbiology, immunology, and clinical descriptions of infections, diagnosis, treatment, and drug resistance.

In addition to original research, the journal will feature editorial commentaries, review articles, case reports, invited key reviews, and articles on practice management. The editors hope to reach and involve clinicians and scientists across such fields as infectious diseases, pulmonology, dermatology, thoracic surgery, urology, pharmacology and microbiology, as well as public health professionals and policy makers. The journal will begin publishing articles individually as they are received, peer-reviewed and accepted.
About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to medical research and education, and providing expert, whole-person care to everyone who needs healing. For more information, visit or

MEDIA CONTACT: Bob Nellis, Mayo Clinic Public Affairs, 507-284-5005, Email:

Mayo Clinic

Related Tuberculosis Articles from Brightsurf:

Scientists find new way to kill tuberculosis
Scientists have discovered a new way of killing the bacteria that cause tuberculosis (TB), using a toxin produced by the germ itself.

Blocking the iron transport could stop tuberculosis
The bacteria that cause tuberculosis need iron to survive. Researchers at the University of Zurich have now solved the first detailed structure of the transport protein responsible for the iron supply.

Tuberculosis: New insights into the pathogen
Researchers at the University of W├╝rzburg and the Spanish Cancer Research Centre have gained new insights into the pathogen that causes tuberculosis.

Unmasking the hidden burden of tuberculosis in Mozambique
The real burden of tuberculosis is probably higher than estimated, according to a study on samples from autopsies performed in a Mozambican hospital.

HIV/tuberculosis co-infection: Tunneling towards better diagnosis
1.2 million people in the world are co-infected by the bacteria which causes tuberculosis and AIDS.

Reducing the burden of tuberculosis treatment
A research team led by MIT has developed a device that can lodge in the stomach and deliver antibiotics to treat tuberculosis, which they hope will make it easier to cure more patients and reduce health care costs.

Tuberculosis: Commandeering a bacterial 'suicide' mechanism
The bacteria responsible for tuberculosis can be killed by a toxin they produce unless it is neutralized by an antidote protein.

A copper bullet for tuberculosis
Tuberculosis is a sneaky disease, and the number one cause of death from infectious disease worldwide.

How damaging immune cells develop during tuberculosis
Insights into how harmful white blood cells form during tuberculosis infection point to novel targets for pharmacological interventions, according to a study published in the open-access journal PLOS Pathogens by Valentina Guerrini and Maria Laura Gennaro of Rutgers New Jersey Medical School, and colleagues.

How many people die from tuberculosis every year?
The estimates for global tuberculosis deaths by the World Health Organisation (WHO) and the Institute for Health Metrics and Evaluation (IHME) differ considerably for a dozen countries, according to a study led by ISGlobal.

Read More: Tuberculosis News and Tuberculosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to